Report Detail

Pharmaceuticals & Healthcare Binge Eating Disorder - Pipeline Review, H2 2018

  • RnM2474172
  • |
  • 11 October, 2018
  • |
  • Global
  • |
  • 50 pages
  • |
  • Global Markets Direct
  • |
  • Pharmaceuticals & Healthcare

Binge Eating Disorder - Pipeline Review, H2 2018

Table of Contents

    List of Tables

      List of Figures

        Introduction

          Global Markets Direct Report Coverage

            Binge Eating Disorder - Overview

              Binge Eating Disorder - Therapeutics Development

                Pipeline Overview

                  Pipeline by Companies

                    Products under Development by Companies

                      Binge Eating Disorder - Therapeutics Assessment

                        Assessment by Target

                          Assessment by Mechanism of Action

                            Assessment by Route of Administration

                              Assessment by Molecule Type

                                Binge Eating Disorder - Companies Involved in Therapeutics Development

                                  Chronos Therapeutics Ltd

                                    F. Hoffmann-La Roche Ltd

                                      Heptares Therapeutics Ltd

                                        Novo Nordisk AS

                                          Omeros Corp

                                            Opiant Pharmaceuticals Inc

                                              Sunovion Pharmaceuticals Inc

                                                Binge Eating Disorder - Drug Profiles

                                                  ANS-6637 - Drug Profile

                                                    Product Description

                                                      Mechanism Of Action

                                                        R&D Progress

                                                          CT-010018 - Drug Profile

                                                            Product Description

                                                              Mechanism Of Action

                                                                R&D Progress

                                                                  CTDP-002 - Drug Profile

                                                                    Product Description

                                                                      Mechanism Of Action

                                                                        R&D Progress

                                                                          dasotraline - Drug Profile

                                                                            Product Description

                                                                              Mechanism Of Action

                                                                                R&D Progress

                                                                                  OMS-527 - Drug Profile

                                                                                    Product Description

                                                                                      Mechanism Of Action

                                                                                        R&D Progress

                                                                                          OPNT-001 - Drug Profile

                                                                                            Product Description

                                                                                              Mechanism Of Action

                                                                                                R&D Progress

                                                                                                  RO-5256390 - Drug Profile

                                                                                                    Product Description

                                                                                                      Mechanism Of Action

                                                                                                        R&D Progress

                                                                                                          Saxenda - Drug Profile

                                                                                                            Product Description

                                                                                                              Mechanism Of Action

                                                                                                                R&D Progress

                                                                                                                  SERx-480 - Drug Profile

                                                                                                                    Product Description

                                                                                                                      Mechanism Of Action

                                                                                                                        R&D Progress

                                                                                                                          Small Molecule to Antagonize Orexin 1 for Central Nervous System Disorders - Drug Profile

                                                                                                                            Product Description

                                                                                                                              Mechanism Of Action

                                                                                                                                R&D Progress

                                                                                                                                  Binge Eating Disorder - Dormant Projects

                                                                                                                                    Binge Eating Disorder - Discontinued Products

                                                                                                                                      Binge Eating Disorder - Product Development Milestones

                                                                                                                                        Featured News & Press Releases

                                                                                                                                          Jul 25, 2018: Sunovion announces positive top-line results from pivotal study evaluating Dasotraline in adults with binge eating disorder

                                                                                                                                            May 02, 2018: Sunovion to Present Data on dasotraline at the 2018 American Psychiatric Association Annual Meeting

                                                                                                                                              Sep 14, 2017: Sunovion to Present Data on Dasotraline at the 2017 Psych Congress

                                                                                                                                                Aug 31, 2017: Sunovion Submits New Drug Application for Dasotraline to the FDA for the Treatment of Patients with ADHD

                                                                                                                                                  May 23, 2017: Sunovion Announces Positive Results from Pivotal Study Evaluating Novel Drug Candidate Dasotraline in Adults with Binge Eating Disorder at Annual American Psychiatric Association Meeting

                                                                                                                                                    May 16, 2017: Sunovion to Present Data on Dasotraline at Annual American Psychiatric Association Meeting Showcase

                                                                                                                                                      Jan 13, 2017: Sunovion Announces Top-line Results from Studies Evaluating Dasotraline in Adults with Binge Eating Disorder and Attention Deficit Hyperactivity Disorder

                                                                                                                                                        Oct 06, 2016: Study Finds New Approach to Block Binge Eating

                                                                                                                                                          Jan 25, 2016: Sunovion Announces Results from a Study Evaluating the Abuse Potential of Investigational Drug Dasotraline

                                                                                                                                                            Appendix

                                                                                                                                                              Methodology

                                                                                                                                                                Coverage

                                                                                                                                                                  Secondary Research

                                                                                                                                                                    Primary Research

                                                                                                                                                                      Expert Panel Validation

                                                                                                                                                                        Contact Us

                                                                                                                                                                          Disclaimer

                                                                                                                                                                          Binge Eating Disorder - Pipeline Review, H2 2018

                                                                                                                                                                          Summary

                                                                                                                                                                          Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Binge Eating Disorder - Pipeline Review, H2 2018, provides an overview of the Binge Eating Disorder (Central Nervous System) pipeline landscape.

                                                                                                                                                                          Binge eating disorder is a serious condition characterized by uncontrollable eating and resulting weight gain. The causes of binge-eating disorder are unknown. But family history, biological factors, long-term dieting and psychological issues increase risk. Signs and symptoms include eating unusually large amounts of food, frequently eating alone, feeling that eating behavior is out of control and experiencing depression and anxiety. Treatment includes psychotherapy, medications and behavioral weight-loss programs.

                                                                                                                                                                          Report Highlights

                                                                                                                                                                          Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Binge Eating Disorder - Pipeline Review, H2 2018, provides comprehensive information on the therapeutics under development for Binge Eating Disorder (Central Nervous System), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

                                                                                                                                                                          The Binge Eating Disorder (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Binge Eating Disorder and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Phase III, Phase II, Phase I and Preclinical stages are 2, 1, 1 and 6 respectively.

                                                                                                                                                                          Binge Eating Disorder (Central Nervous System) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

                                                                                                                                                                          Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.

                                                                                                                                                                          Scope

                                                                                                                                                                          - The pipeline guide provides a snapshot of the global therapeutic landscape of Binge Eating Disorder (Central Nervous System).
                                                                                                                                                                          - The pipeline guide reviews pipeline therapeutics for Binge Eating Disorder (Central Nervous System) by companies and universities/research institutes based on information derived from company and industry-specific sources.
                                                                                                                                                                          - The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
                                                                                                                                                                          - The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
                                                                                                                                                                          - The pipeline guide reviews key companies involved in Binge Eating Disorder (Central Nervous System) therapeutics and enlists all their major and minor projects.
                                                                                                                                                                          - The pipeline guide evaluates Binge Eating Disorder (Central Nervous System) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
                                                                                                                                                                          - The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
                                                                                                                                                                          - The pipeline guide reviews latest news related to pipeline therapeutics for Binge Eating Disorder (Central Nervous System)

                                                                                                                                                                          Reasons to buy

                                                                                                                                                                          - Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
                                                                                                                                                                          - Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
                                                                                                                                                                          - Find and recognize significant and varied types of therapeutics under development for Binge Eating Disorder (Central Nervous System).
                                                                                                                                                                          - Classify potential new clients or partners in the target demographic.
                                                                                                                                                                          - Develop tactical initiatives by understanding the focus areas of leading companies.
                                                                                                                                                                          - Plan mergers and acquisitions meritoriously by identifying key players and it’s most promising pipeline therapeutics.
                                                                                                                                                                          - Formulate corrective measures for pipeline projects by understanding Binge Eating Disorder (Central Nervous System) pipeline depth and focus of Indication therapeutics.
                                                                                                                                                                          - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
                                                                                                                                                                          - Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.


                                                                                                                                                                          Summary:
                                                                                                                                                                          Get latest Market Research Reports on Binge Eating Disorder. Industry analysis & Market Report on Binge Eating Disorder is a syndicated market report, published as Binge Eating Disorder - Pipeline Review, H2 2018. It is complete Research Study and Industry Analysis of Binge Eating Disorder market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.


                                                                                                                                                                          REPORT YOU MIGHT BE INTERESTED

                                                                                                                                                                          Purchase this Report

                                                                                                                                                                          $2,000.00
                                                                                                                                                                          $4,000.00
                                                                                                                                                                          $6,000.00
                                                                                                                                                                          1,646.71
                                                                                                                                                                          3,293.42
                                                                                                                                                                          4,940.14
                                                                                                                                                                          1,802.91
                                                                                                                                                                          3,605.82
                                                                                                                                                                          5,408.73
                                                                                                                                                                          212,564.00
                                                                                                                                                                          425,128.00
                                                                                                                                                                          637,692.00
                                                                                                                                                                          142,596.20
                                                                                                                                                                          285,192.40
                                                                                                                                                                          427,788.60
                                                                                                                                                                          Credit card Logo

                                                                                                                                                                          Related Reports


                                                                                                                                                                          Reason to Buy

                                                                                                                                                                          Request for Sample of this report